Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to 2029—click here to read now.
Grants Awarded to Two Patient Advocacy Organizations to Support Communications and Community OutreachSOUTH SAN FRANCISCO, Calif., Feb. 09, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results